Literature DB >> 16505501

Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey.

Helaine E Resnick1, Gregory L Foster, Joan Bardsley, Robert E Ratner.   

Abstract

OBJECTIVE: To estimate the proportion of U.S. adults with diabetes who meet American Diabetes Association (ADA) clinical practice recommendations. RESEARCH DESIGN AND METHODS: Using data from the 1999-2002 National Health and Nutrition Examination Survey, 998 adults aged >/=18 years with self-reported diabetes were identified. The proportion of adults with diabetes meeting ADA recommendations for HbA(1c) (A1C), HDL cholesterol, LDL cholesterol, triglycerides, blood pressure, renal function, nutrient intake, smoking, pneumococcal vaccination, and physical activity was estimated.
RESULTS: Among U.S. adults with diabetes in 1999-2002, 49.8% had A1C <7%; 27.4, 36.0, and 65.0% were classified as low risk for HDL cholesterol, LDL cholesterol, and triglycerides, respectively. Nearly 40% met blood pressure recommendations, 66% had normal renal function, and daily nutrient recommendations for protein, saturated fat, unsaturated fat, and fiber were met by 64.0, 48.3, 28.3, and 18.3%, respectively. Although >81% of the sample reported not smoking at the time of the exam, only 38.2% reported ever having had a pneumococcal immunization, and 28.2% reported getting the recommended level of physical activity. Race, age, duration of diabetes, and education affected achievement of ADA recommendations.
CONCLUSIONS: Achievement of ADA clinical practice recommendations is far from adequate in U.S. adults with diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505501     DOI: 10.2337/diacare.29.03.06.dc05-1254

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  141 in total

1.  Liraglutide (victoza): the first once-daily incretin mimetic injection for type-2 diabetes.

Authors:  Sylvia H Jackson; Tonya S Martin; Jocelyn D Jones; David Seal; Frank Emanuel
Journal:  P T       Date:  2010-09

Review 2.  The efficacy and safety of liraglutide.

Authors:  Kyeong-Hye Jeong; Bong Kyu Yoo
Journal:  Int J Clin Pharm       Date:  2011-09-28

3.  Measuring Physical Activity and Sedentary Behavior in Youth with Type 2 Diabetes.

Authors:  Bonny Rockette-Wagner; Kristi L Storti; Sharon Edelstein; Linda M Delahanty; Bryan Galvin; Alexandra Jackson; Andrea M Kriska
Journal:  Child Obes       Date:  2016-02-09       Impact factor: 2.992

Review 4.  Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus: A Meta-Analysis and Systematic Review.

Authors:  An Pan; Yeli Wang; Mohammad Talaei; Frank B Hu
Journal:  Circulation       Date:  2015-08-26       Impact factor: 29.690

Review 5.  Orlistat: Current issues for patients with type 2 diabetes.

Authors:  Juliet M Mancino
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

6.  Sitagliptin: a viewpoint by Mark S. Kipnes.

Authors:  Mark S Kipnes
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Microangiopathy in older patients with diabetes mellitus.

Authors:  Robert C Stanton
Journal:  Curr Diab Rep       Date:  2007-12       Impact factor: 4.810

Review 8.  Daily physical activity and type 2 diabetes: A review.

Authors:  Hidetaka Hamasaki
Journal:  World J Diabetes       Date:  2016-06-25

9.  Effects of the 2013 American College of Cardiology/American Heart Association guidelines on racial and ethnic disparities in statin treatment among diabetics.

Authors:  Gregory A Phelps; Yanru Qiao; Merrion G Buckley; Junling Wang; Minghui Sam Li; Soumitra S Bhuyan; Marie A Chisholm-Burns
Journal:  Res Social Adm Pharm       Date:  2019-07-25

Review 10.  Novel and emerging diabetes mellitus drug therapies for the type 2 diabetes patient.

Authors:  Charmaine D Rochester; Oluwaranti Akiyode
Journal:  World J Diabetes       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.